Executive Overview Blood transfusions remain a cornerstone in the management of sickle cell anemia (SCA), acting as a vital intervention for acute chest syndrome, stroke, and severe symptomatic anemia. However,...
A comprehensive new real-world observational study utilizing United States administrative claims data has revealed that adults living with...
Executive Overview Polycythemia Vera (PV) and related Philadelphia-negative myeloproliferative neoplasms (MPNs)—such as essential thrombocythemia (ET) and myelofibrosis (MF)—represent...
Executive Overview In the realm of rare hematology, the convergence of multiple complex pathologies presents an extraordinary diagnostic...
Executive Overview In the intricate landscape of hematology, pancytopenia—a dangerous reduction in red blood cells, white blood cells,...
Revolutionary immunotherapies such as Chimeric Antigen Receptor (CAR) T-cell therapy and T-cell engaging bispecific antibodies (BsAbs) have fundamentally...
Chimeric antigen receptor T-cell (CAR T) therapy stands as one of the most remarkable breakthroughs in modern oncology....
Executive Overview Cutaneous T-cell lymphomas (CTCLs) represent a complex and heterogeneous family of clonal lymphoproliferative disorders originating from...
Executive Overview Acute lymphoblastic leukemia (ALL) remains the most prevalent pediatric malignancy globally, yet a profound geopolitical divide...
Executive Overview Acute promyelocytic leukemia (APL) has long been considered one of the great success stories of modern...
Executive Overview For more than half a century, cytotoxic chemotherapy has achieved a monumental milestone in modern medicine:...
Executive Overview For decades, disease relapse following an allogeneic hematopoietic cell transplantation (allo-HCT)—the high-stakes curative procedure for acute...
